Novartis announced in a March 20, 2020 press release that it is committing to donate up to 130 million doses of generic hydroxychloroquine to support the global COVID-19 pandemic response. Hydroxychloroquine and a related drug, chloroquine,... Read More >

FDA announced that the agency will temporarily postpone all domestic routine surveillance facility inspections, those conducted every few years based on a risk analysis. In a March 18, 2020 statement, FDA Commissioner Stephen M. Hahn said t... Read More >

Abbott Laboratories, one of the biggest players in the medical device space, has obtained Emergency Use Authorization for a test to detect the coronavirus [COVID-19]. The Abbott Park, IL-based company joins the rapidly expanding list of com... Read More >

The Association of the British Pharmaceutical Industry (ABPI) has issued a statement noting that it shares the ambition of the United Kingdoms government, as set out in its published approach to the negotiations for the future relationship... Read More >

Swift Biosciences has partnered with LGC Biosearch Technologies to incorporate Swift's targeted sequencing technology into LGC's kits and service offerings for the worldwide ag-bio market.... Read More >

Natera reported after the close of the market on Wednesday that its fourth quarter 2019 revenues grew 24 percent year over year. Read More >

Swift Biosciences has partnered with LGC Biosearch Technologies to incorporate Swift's targeted sequencing technology into LGC's kits and service offerings for the worldwide ag-bio market.... Read More >

Illumina has asked a US Court for a preliminary injunction to prevent BGI from distributing sequencers in the US to a handful of labs on a no-cost trial basis.... Read More >

Fluidigm said on Wednesday that it has completed the acquisition of InstruNor, a privately held, Oslo-based provider of integrated sample preparation systems for flow and mass cytometry.... Read More >

The US International Trade Commission has upheld a judge's previous determination that certain microfluidic products imported by Bio-Rad Laboratories indirectly infringe patents held by 10x Genomics.... Read More >